Molex to Acquire Phillips-Medisize Corporation

Aug. 17, 2016
Molex, LLC recently announced that one of its subsidiaries has entered into a binding agreement to acquire Phillips-Medisize Corporation.

Molex, LLC recently announced that one of its subsidiaries has entered into a binding agreement to acquire Phillips-Medisize Corporation. The agreement is subject to customary closing conditions and is expected to close in the fall. Financial terms of the transaction were not disclosed.

Phillips-Medisize, which is headquartered in Hudson, WI, specializes in the medical device and diagnostics, drug delivery, and primary pharmaceutical packaging markets. It has a global design network that supports North America, Europe and China and employs more than 4,300 people in 17 production locations throughout the United States, Europe, Mexico and China. Phillips-Medisize Corporation will operate as an indirect subsidiary of Molex, LLC.

“Phillips-Medisize has a talented, experienced and innovative team that has strong customer relationships because of its outstanding ability to serve the unique needs of the medical solutions market,” said Tim Ruff, senior vice president of business development and corporate strategy, Molex, LLC. “Combined with Molex’s expertise in electronics and broad global manufacturing presence, we are confident that together we can significantly expand our medical solutions capabilities globally.”

“Molex and Phillips-Medisize share a similar culture and approach to managing the business that creates strong partnerships built on quality and innovation,” said Matt Jennings, chairman, president and CEO, Phillips-Medisize Corporation. “Molex’s global scale in electronics, coupled with Phillips-Medisize’s strength in designing and manufacturing innovative products for medical device customers, will help us become a global leader in connected health solutions.”

Rajeev Amara, a Managing Director of Golden Gate Capital stated, "In just three years of our ownership, Phillips-Medisize has executed on a transformative vision to become a global leader in the manufacturing of biologics drug delivery devices. We would like to thank all the employees for their hard work and wish them well in the future."

Molex’s exclusive financial advisor is Morgan Stanley & Co. LLC.

>>For more information, click here.

Sponsored Recommendations

Why Go Beyond Traditional HMI/SCADA

Traditional HMI/SCADAs are being reinvented with today's growing dependence on mobile technology. Discover how AVEVA is implementing this software into your everyday devices to...

4 Reasons to move to a subscription model for your HMI/SCADA

Software-as-a-service (SaaS) gives you the technical and financial ability to respond to the changing market and provides efficient control across your entire enterprise—not just...

Is your HMI stuck in the stone age?

What happens when you adopt modern HMI solutions? Learn more about the future of operations control with these six modern HMI must-haves to help you turbocharge operator efficiency...

AVEVA™ System Platform: Smarter, Faster Operations for Enhanced Industrial Performance

AVEVA System Platform (formerly Wonderware) delivers a responsive, modern operations visualization framework designed to enhance performance across all devices with context-aware...